Urolift: New Minimally Invasive Treatment for BPH with Fewest Sexual Side Effects
Urolift for BPH is unique among treatment options for BPH in that it does not cause sexual side effects based on the studies reviewed by the FDA.
Randomized controlled studies published in the Journal of Urology and submitted to the FDA have shown a durable benefit for >5 years after the procedure with minimal side effects and high patient satisfaction. In fact, studies suggest that sexual function improves after treatment.
Urolift is appropriate for men with an enlarged prostate and urinary symptoms who do not want to take daily medications or who wish to avoid the side effects associated with other treatment options for BPH such as TURP, Greenlight laser and Flomax. It is most appropriate for men with obstructing prostate with mild to moderate enlargement. Some men with more severe urinary symptoms including urinary retention may be candidates for Urolift.
Some men with urinary symptoms as a result of prostate cancer may also benefit from Urolift.
How does Urolift Work?
The UroLift procedure is distinctive in that it does not involve the destruction of tissue. Instead, UroLift works by compressing the obstructing tissue in the urethra, resulting in a wider, unobstructed urethra and improved urine flow. The image below illustrates the significant impact of UroLift treatment on the urethra and prostate before and after the procedure.
Urolift has very good efficacy for men who are good candidates for the procedure based on a thorough evaluation. For men who are considered a good candidate for Urolift, success rates are around 90%. When Urolift does not achieve the desired results, other treatment options after the Urolift procedure are available. Procedures such as Microwave, Greenlight laser and TURP can be performed for patients who fail Urolift therapy for BPH.
